RT Book, Section
A1 Appel, Betsy L.
A1 Tolat, Parag
A1 Oshima, Kiyoko
A1 Evans, Douglas B.
A1 Tsai, Susan
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145764726
T1 Clinical and Pathologic Staging for Pancreatic Cancer
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK accesssurgery.mhmedical.com/content.aspx?aid=1145764726
RD 2024/09/16
AB Cancer  staging  systems  have  been  designed  to  provide  both  physicians  and  patients  with  a  metric  for  assessing  the  extent  of  disease  and  prognosis.  Staging  systems  provide  a  universal  classification  that  describes  the  extent  of  disease.  This  classification  impacts  individual  stage-specific  treatment,  the  development  of  practice  guidelines,  and  the  design  of  clinical  research/trials.  Cancer  staging  is  therefore  the  foundation  on  which  all  clinical  cares  are  based  and  is  essential  for  the  rigorous  study  of  cancer  therapies.